I 
119TH CONGRESS 
1ST SESSION 
H. R. 498 
To amend title XIX of the Social Security Act to prohibit Federal Medicaid 
funding for gender transition procedures for minors. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 16, 2025 
Mr. CRENSHAW (for himself and Ms. GREENE of Georgia) introduced the 
following bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To amend title XIX of the Social Security Act to prohibit 
Federal Medicaid funding for gender transition proce-
dures for minors. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Do No Harm in Med-
icaid Act’’. 
SEC. 2. PROHIBITING FEDERAL MEDICAID FUNDING FOR 
GENDER TRANSITION FOR MINORS. 
(a) IN GENERAL.—Section 1903(i) of the Social Se-
curity Act (42 U.S.C. 1396b(i)) is amended— 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS
(1) in paragraph (26), by striking ‘‘; or’’ and 
inserting a semicolon; 
(2) in paragraph (27), by striking the period at 
the end and inserting ‘‘; or’’; and 
(3) by inserting after paragraph (27) the fol-
lowing new paragraph: ‘‘(28) with respect to any 
amount expended for specified gender procedures 
under section 1905(kk) to an individual under 18 
years of age enrolled in a State plan (or waiver of 
such plan), including any amounts expended for the 
administration of a State program that furnishes 
specified procedures and drugs to individuals under 
18 years of age.’’. 
(4) in the flush left matter at the end, by strik-
ing ‘‘and (18),’’ and inserting ‘‘(18), and (28)’’. 
(b) PROHIBITING FEDERAL MEDICAID FUNDING FOR 
GENDER TRANSITIONS FOR MINORS.—Section 1905 of 
the Social Security Act (42 U.S.C. 1396d) is amended by 
adding at the end the following new subsection: 
‘‘(KK) PROHIBITING FEDERAL MEDICAID 
FUNDING FOR GENDER TRANSITIONS FOR MI-
NORS.— 
‘‘(A) For purposes of section 1903(i)(28), 
except as provided in subparagraph (B), the 
term ‘specified gender transition procedures’ 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS
means, with respect to an individual, any of the 
following when performed for the purpose of in-
tentionally changing the body of such individual 
(including by disrupting the body’s develop-
ment, inhibiting its natural functions, or modi-
fying its appearance) to no longer correspond to 
the individual’s sex: 
‘‘(i) Performing any surgery, includ-
ing— 
‘‘(I) castration; 
‘‘(II) sterilization; 
‘‘(III) orchiectomy; 
‘‘(IV) scrotoplasty; 
‘‘(V) vasectomy; 
‘‘(VI) tubal ligation; 
‘‘(VII) hysterectomy; 
‘‘(VIII) oophorectomy; 
‘‘(IX) ovariectomy; 
‘‘(X) metoidioplasty; 
‘‘(XI) clitoroplasty; 
‘‘(XII) reconstruction of the fixed 
part of the urethra with or without a 
metoidioplasty or a phalloplasty; 
‘‘(XIII) penectomy; 
‘‘(XIV) phalloplasty; 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(XV) vaginoplasty; 
‘‘(XVI) vaginectomy; 
‘‘(XVII) vulvoplasty; 
‘‘(XVIII) 
reduction 
thyrochondroplasty; 
‘‘(XIX) chondrolaryngoplasty; 
‘‘(XX) mastectomy; and 
‘‘(XXI) any plastic, cosmetic, or 
aesthetic surgery that feminizes or 
masculinizes the facial or other phys-
iological features of an individual. 
‘‘(ii) Any placement of chest implants 
to create feminine breasts or any place-
ment of erection or testicular prosetheses. 
‘‘(iii) Any placement of fat or artifi-
cial implants in the gluteal region. 
‘‘(iv) Administering, supplying, pre-
scribing, dispensing, distributing, or other-
wise conveying to an individual medica-
tions, including— 
‘‘(I) gonadotropin-releasing hor-
mone (GnRH) analogues or other pu-
berty-blocking drugs to stop or delay 
normal puberty; and 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(II) testosterone, estrogen, pro-
gesterone or other androgens to an in-
dividual 
at 
doses 
that 
are 
supraphysiologic, greater or more po-
tent than would normally be produced 
endogenously in a healthy individual 
of the same age and sex. 
‘‘(B) 
EXCEPTION.—Subparagraph 
(A) 
shall not apply to the following when furnished 
to an individual by a health care provider with 
the consent of such individual’s parent or legal 
guardian: 
‘‘(i) Puberty suppression or blocking 
prescription drugs for the purpose of nor-
malizing puberty for an individual experi-
encing precocious puberty. 
‘‘(ii) Appropriate and medically nec-
essary procedures or treatments to correct 
for— 
‘‘(I) a medically verifiable genetic 
disorder of sex development, includ-
ing— 
‘‘(aa) 46,XX chromosomes 
with virilization; 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(bb) 46,XY chromosome 
with undervirilization; and 
‘‘(cc) both ovarian and tes-
ticular tissue; 
‘‘(II) sex chromosome structure, 
sexsteroid hormone production, or sex 
hormone action, if determined to be 
abnormal for a healthy individual of 
the same sex and age by a physician 
through genetic or biochemical test-
ing; 
‘‘(III) infection, disease, injury, 
or disorder caused or exacerbated by a 
previous procedure described in sub-
paragraph (A), or a physical disorder, 
physical injury, or physical illness that 
would, as certified by a physician, 
place the individual in imminent dan-
ger of death or impairment of a major 
bodily function unless the procedure is 
performed, not including procedures 
performed for the alleviation of men-
tal distress; or 
‘‘(IV) procedures to restore or re-
construct the body of the individual in 
VerDate Sep 11 2014 
21:54 Feb 19, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H498.IH
H498
ssavage on LAPJG3WLY3PROD with BILLS